Human renal cancer stem cells

Cancer Lett. 2013 Sep 10;338(1):141-6. doi: 10.1016/j.canlet.2012.05.007. Epub 2012 May 12.

Abstract

Cancer stem cells (CSCs), isolated in renal carcinomas, exhibit tumor-initiating capabilities and pluripotency. No specific CSC markers have been identified so far; therefore, their characterization is mainly based on functional studies. As they are resistant to chemo and radio therapy, renal CSCs may have a relevant role in tumor establishment, progression, and recurrence. CSCs were also shown to contribute to intra-tumor vasculogenesis through an endothelial differentiation and to favor the generation of the pre-metastatic niche through the release of exosomes/microvesicles.

Keywords: Angiogenesis; Differentiation therapy; Renal cell carcinoma; Tumor stem cells; Wilms’ tumor.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Antigens, CD / metabolism
  • Carcinoma, Renal Cell / blood supply
  • Carcinoma, Renal Cell / drug therapy
  • Carcinoma, Renal Cell / pathology*
  • Cell Differentiation
  • Endoglin
  • Endothelial Cells / drug effects
  • Endothelial Cells / metabolism
  • Endothelial Cells / pathology*
  • Humans
  • Interleukin-15 / therapeutic use
  • Kidney Neoplasms / blood supply
  • Kidney Neoplasms / drug therapy
  • Kidney Neoplasms / pathology*
  • Models, Biological
  • Neoplastic Stem Cells / drug effects
  • Neoplastic Stem Cells / metabolism
  • Neoplastic Stem Cells / pathology*
  • Receptors, Cell Surface / metabolism

Substances

  • Antigens, CD
  • ENG protein, human
  • Endoglin
  • Interleukin-15
  • Receptors, Cell Surface